Elasmogen, which is part of the Deepbridge Life Sciences EIS portfolio, are to collaborate with the University of Aberdeen as partner on a Scottish research award to assist with critical research to tackle the COVID-19 pandemic.
Caroline Barelle, CEO of Elasmogen commented;
“The Elasmogen team are delighted to be given the opportunity to deploy our soloMER technology platform..and are proud to be contributing to the global life sciences effort tackling this pandemic by working together with colleagues in Universities and other companies”.
- November 2019 (6)
- October 2019 (7)
- September 2019 (7)
- August 2019 (5)
- July 2019 (4)
- June 2019 (1)
- May 2019 (5)
- April 2019 (6)
- March 2019 (4)
- February 2019 (4)
- January 2019 (5)
- December 2018 (1)
- November 2018 (1)
- October 2018 (4)
- September 2018 (7)
- August 2018 (2)
- July 2018 (2)
- June 2018 (2)
